Treatment of coronary heart disease angina pectoris from the five internal organs

Clinical study of isosorbide mononitrate treatment for angina pectoris in coronary heart disease

The aim of this study was to observe and investigate the clinical efficacy of an intravenous drip of isosorbide mononitrate (ISMN) for the treatment of angina pectoris in coronary heart disease. A total of 102 patients with angina pectoris in coronary heart disease were divided into two groups. For the treatment group (n=51), 20 mg ISMN was added to 250 ml 0.9% normal saline and administered by...

Coronary disease CHRONIC THERAPEUTICALLY REFRACTORY ANGINA PECTORIS

Correspondence to: Dr Mike J L DeJongste, Department of Cardiology, Thoraxcenter, University Hospital of Groningen, PO Box 30,001, 9700 RB Groningen, The Netherlands; m.j.l.de.jongste@ thorax.azg.nl _________________________ I n contrast to the tremendous increase in practical opportunities and theoretical knowledge in the western world, resulting in a doubling of our average life expectancy, t...

Coronary sinus intervention for the treatment of refractory angina pectoris

The Heart Laser(TM): transmyocardial revascularization treatment of angina pectoris.

Frequency of angina pectoris and secondary events in patients with stable coronary heart disease (from the Heart and Soul Study).

The extent to which angina pectoris (AP) predicts secondary cardiovascular events beyond independent of measures of disease severity is unknown. We evaluated the association between AP frequency and secondary events in patients with stable coronary heart disease (CHD). We administered the Seattle Angina Questionnaire to 1,023 participants with stable CHD enrolled from September 2000 to December...